We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Age No Barrier to Cochlear Implants

By HospiMedica staff writers
Posted on 11 Jan 2006
Age has no effect on outcome after implantation of a cochlear device among people over 65, a study has found, suggesting that elderly patients should not be discriminated against in assessments for cochlear implant candidacy.

To help clarify the effect of age on outcome, Dr. More...
John K. Niparko of the Johns Hopkins University (Baltimore, MD, USA) and colleagues examined 749 people who had undergone the procedure and who ranged in age from 14 to 91 years.

Although those 65 years of age and older had a 4.6% lower score on postoperative monosyllabic word recognition tests, this difference was not significant, the researchers noted, and may not be clinically detectable. Longer duration of deafness was typically tied to worse performance on word recognition tests. However, among people who had been deaf for longer than 25 years, the older implant recipients scored higher than younger patients.

This suggests, the researchers say, that variables beyond age may be involved in implant outcome, such as early language learning and residual hearing. The results were published in the December 2005 edition of the Archives of Otolaryngology/Head and Neck Surgery.

A cochlear implant is a small electronic device surgically placed under the skin behind the ear. It can help provide a sense of sound to someone who is profoundly deaf or severely hard of hearing. The device does not restore or create normal hearing, but under the right conditions it can give deaf people a useful auditory understanding of the environment around them and help them understand speech.

"A foundation of central auditory processing in the older cohort,” the study states, "may actually mitigate the disadvantage of advanced age at implantation, build on adaptive skills, and help explain the encouraging results of this study.”




Related Links:
Johns Hopkins University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.